Associations between sweetened beverage consumption, degenerative valvular heart disease, and related events: a

Cheng Wei1,2,3, Wen Gong1,2, Binyi Xu1,2

  • 1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, 410011 Changsha, Hunan, China.

Insights

Reducing intake of sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) may lower the risk of developing valvular heart disease (VHD). This study found higher consumption linked to increased VHD incidence.

Area of Science:

  • Cardiovascular Medicine
  • Nutritional Epidemiology
  • Public Health

Background:

  • Degenerative valvular heart disease (VHD) lacks effective preventive medications.
  • Sweetened beverage consumption is a potential risk factor for VHD through metabolic and inflammatory pathways.

Purpose of the Study:

  • To prospectively investigate the association between sweetened beverage intake and the risk of developing degenerative VHD.
  • To differentiate the risks associated with sugar-sweetened beverages (SSBs), artificially sweetened beverages (ASBs), and natural juices (NJs).

Main Methods:

  • Prospective cohort study utilizing UK Biobank data from 167,801 participants.
  • Dietary intake assessed via questionnaires, with a median follow-up of 14.53 years.
  • Incidence of aortic valve stenosis (AS), aortic regurgitation (AR), and mitral regurgitation (MR) events were recorded and analyzed.

Main Results:

  • Higher consumption of ASBs was linked to increased risk of AS, AR, and MR.
  • Increased SSB intake was associated with a higher incidence of MR.
  • No significant association was found between natural juice consumption and VHD risk.

Conclusions:

  • Reducing intake of SSBs and ASBs may lower the risk of degenerative VHD.
  • Substituting SSBs or ASBs with natural juices may mitigate VHD risk.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
244
Heart Valves01:17

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
3.9K
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
515
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.2K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K